Background. Previous studies have demonstrated that tumor cells have different degrees of sensitivity and resistance to various cytotoxic agents. The acquisition of drug resistance is a major concern in cancer treatment. The current study investigates the cytotoxic effect of cisdiamminedichloroplati
Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitization
✍ Scribed by Youichi Mizutani; Osamu Yoshida
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 871 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Resistance to apoptosis may be responsible for a principal mechanism by which cancer cells overcome anticancer therapies. among antiapoptotic signals, the transcription factor, nf-kappab, plays a pivotal role in the resistance because it is frequently activated in many primary carcin
proliferative response of the liver to mitogens, de-A single intravenous injection of lead nitrate (LN) to pending on the capacity of the mitogens to stimulate rats induces liver cell proliferation without causing cell TNF-a production. (HEPATOLOGY 1996;23:1572-1577.) necrosis (direct hyperplasia).
Ovarian cancer arises mostly from the ovarian surface epithelium. The aim of our study was to compare the effects of cytokines in ovarian surface epithelial (OSE) cells and in ovarian carcinoma cells. Proliferation and expression of surface antigens (CA-I25 and classes I and II antigens of the major
## BACKGROUND. Previous studies have demonstrated that treatment of human tumor cell lines with a combination of cis-diamminedichloroplatinum (CDDP) and tumor necrosis factor-a (TNF-a) results in additivelsynergistic cytotoxic effects and reverses tumor cell resistance to TNF drugs. Free radical i